Related Experiment Video
Updated: Jul 22, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Percutaneous left atrial appendage closure in patients with gastrointestinal bleeding associated with oral
Patricia Sanz Segura1, Javier Jimeno Sánchez2, José Miguel Arbonés-Mainar3,4,5
1Gastroenterology Department, Royo Villanova Hospital, Zaragoza, Spain.
Insights
Percutaneous left atrial appendage closure (LAAC) significantly reduced gastrointestinal bleeding and chronic anemia in atrial fibrillation patients. This procedure also led to substantial reductions in healthcare resource utilization, offering a safe alternative to oral anticoagulation.
Area of Science:
- Cardiology
- Interventional Cardiology
- Gastroenterology
Background:
- Atrial fibrillation (AF) patients often require oral anticoagulation (OAC) to prevent stroke.
- OAC is associated with an increased risk of gastrointestinal bleeding (GIB) and chronic anemia.
- Left atrial appendage closure (LAAC) is an alternative stroke prevention strategy in AF.
Purpose of the Study:
- To evaluate the effectiveness of percutaneous LAAC in reducing GIB and chronic anemia in AF patients.
- To assess the impact of LAAC on healthcare resource consumption compared to OAC.
- To determine the safety of LAAC as an alternative to OAC in specific patient populations.
Main Methods:
- Prospective, single-center study conducted from 2016 to 2022.
- Collected clinical, analytical, and healthcare resource data (endoscopies, transfusions, hospitalizations) before and 6 months after LAAC.
- Included 43 patients (average age 77.6 years) with indications for LAAC due to GIB.
Main Results:
- LAAC significantly reduced packed red blood cell transfusions (7.29 to 0.42 per patient, p < 0.001).
- Endoscopic procedures and hospitalizations decreased dramatically post-LAAC (p < 0.001 for both).
- Mean hemoglobin levels improved significantly (8.1 to 12.4 g/dL, p < 0.001) with no reported thromboembolic events.
Conclusions:
- Percutaneous LAAC is a safe and effective alternative to OAC for AF patients with significant GIB.
- LAAC can resolve chronic anemia and reduce the need for transfusions and hospitalizations.
- This intervention offers considerable savings in healthcare resource utilization.
Introduction:
Percutaneous left atrial appendage closure (LAAC) has shown non-inferiority compared to oral anticoagulation (OAC) in preventing atrial fibrillation (AF)-related stroke. The objective of this study was to assess whether LAAC reduces the incidence of gastrointestinal bleeding (GIB) and/or chronic anaemia associated with OAC, as well as the consumption of healthcare resources.
Materials And Methods:
Prospective, single-center study from 2016 to 2022, LAAC was performed. Clinical, analytical and healthcare resource consumption data were collected (endoscopies, blood transfusions, hospital admissions) prior and 6 months after LAAC.
Results:
43 patients were included, with an average age of 77.6 years. LAAC indication was upper, low and obscure GIB in 7 (16%), 8 (19%) and 28 patients (65%) respectively. GIB source was intestinal angiodysplasias in 27 patients (63%), occult origin in 12 (28%), and others (antral vascular ectasia, portal hypertension gastropathy, etc.) in 4 patients (9%). The mean number of packed red blood cells per patient before LAAC was (mean ± SD) 7.29 ± 5 vs 0.42 ± 1.3 (p < 0.001); endoscopic procedures were 4.34 ± 2.85 vs 0.27 ± 0.76 (p < 0.001); and hospitalizations 2.67 ± 2.14 vs 0.03 ± 0.17 (p < 0.001), with a hospital stay of 21.5 ± 17.3 vs 0.09 ± 0.5 days (p < 0.001) at 6 months post-intervention. Haemoglobin value increased from 8.1 ± 1.2g/dl to 12.4 ± 2.2g/dl (p < 0.001) at 6 months. No thromboembolic events were registered during a median follow-up of 16.6 months (range 6-65).
Conclusions:
LAAC could be a safe and effective alternative to OAC in patients with non-valvular AF presenting significant, recurrent or potentially unresolvable GIB. This intervention also leads to important savings in the consumption of healthcare resources.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

